Promising new research for Alzheimer’s and Parkinson’s diseases

Director of the ASU-Banner Neurodegenerative Disease Research Center, Jeffrey Kordower, reveals how his team of researchers is in a race against time to find effective treatments, if not a cure, for Alzheimer’s and Parkinson’s diseases.

Researchers explore possible effects in the brain Neurodegenerative illnesses, such as Alzheimer’s disease, are among the most perplexing in medical science. The underlying causes of such diseases range from genetic

Neurodegenerative diseases damage and destroy neurons, ravaging both mental and physical health. Parkinson’s disease, which affects over 10 million people worldwide, is no exception. The most obvious symptoms of Parkinson’s

The Michael J. Fox Foundation has awarded three new grants totaling $5.2 million to Arizona State University (ASU) to explore three pioneering treatments for Parkinson’s disease (PD). The awards will fund research

Editor's note: This story is part of a series of profiles of notable fall 2021 graduates.When the COVID-19 pandemic began, Nikhil Dave knew he had to do something to help. As part of his work

Alzheimer's disease is the most common form of dementia and is characterized by neurodegeneration in regions of the brain involved in memory and learning. Amyloid beta and tau are two

The largest study of its kind has unveiled new insights into how genes are regulated in dementia, including discovering 84 new genes linked to the disease. Researchers from the ASU-Banner Neurodegenerative

Since the discovery of Alzheimer’s disease over a century ago, two hallmarks of the devastating illness have taken center stage. The first, known as amyloid plaques, are dense accumulations of

Arizona State University is honored to announce the appointment of Jeffrey Kordower as the founding director of the ASU-Banner Neurodegenerative Disease Research Center (NDRC) and endowed Chair as The Charlene and J. Orin

Over $300,000 from The Charlene and J. Orin Edson Initiative for Dementia Care and Solutions was awarded to three Arizona State University research teams for innovative research projects. The funding

or researchers investigating Alzheimer’s Disease (AD), a devastating neurodegenerative illness afflicting close to 6 million Americans, it is the best and worst of times. Scientists have made exponential advances in

“My mother was driving to work one morning and was alarmed to see an older man riding a bicycle against traffic,” says Diego Mastroeni. To her surprise, that man was